Ontology highlight
ABSTRACT:
SUBMITTER: Kim RY
PROVIDER: S-EPMC5692535 | biostudies-literature | 2017 Nov
REPOSITORIES: biostudies-literature
Kim Robin Y RY Pless Stephan A SA Kurata Harley T HT
Proceedings of the National Academy of Sciences of the United States of America 20171023 45
Retigabine (RTG) is a first-in-class antiepileptic drug that suppresses neuronal excitability through the activation of voltage-gated KCNQ2-5 potassium channels. Retigabine binds to the pore-forming domain, causing a hyperpolarizing shift in the voltage dependence of channel activation. To elucidate how the retigabine binding site is coupled to changes in voltage sensing, we used voltage-clamp fluorometry to track conformational changes of the KCNQ3 voltage-sensing domains (VSDs) in response to ...[more]